Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Long-Term Investments: 2009-2025

Historic Long-Term Investments for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to $1.6 billion.

  • UNITED THERAPEUTICS's Long-Term Investments rose 22.50% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 22.50%. This contributed to the annual value of $1.5 billion for FY2024, which is 22.75% down from last year.
  • As of Q3 2025, UNITED THERAPEUTICS's Long-Term Investments stood at $1.6 billion, which was down 18.27% from $1.9 billion recorded in Q2 2025.
  • UNITED THERAPEUTICS's 5-year Long-Term Investments high stood at $2.1 billion for Q3 2023, and its period low was $1.3 billion during Q3 2024.
  • Over the past 3 years, UNITED THERAPEUTICS's median Long-Term Investments value was $1.7 billion (recorded in 2025), while the average stood at $1.7 billion.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Long-Term Investments spiked by 65.15% in 2021, and later crashed by 37.92% in 2024.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Long-Term Investments stood at $1.6 billion in 2021, then decreased by 20.23% to $1.3 billion in 2022, then skyrocketed by 45.10% to $1.9 billion in 2023, then decreased by 22.75% to $1.5 billion in 2024, then rose by 22.50% to $1.6 billion in 2025.
  • Its Long-Term Investments stands at $1.6 billion for Q3 2025, versus $1.9 billion for Q2 2025 and $1.7 billion for Q1 2025.